Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[MicroRNA Analysis for Extramedullary Multiple Myeloma Relapse].
Gregorová J, Vrábel D, Radová L, Gablo NA, Almaši M, Štork M, Slabý O, Pour L, Minařík J, Ševčíková S. Gregorová J, et al. Among authors: slaby o. Klin Onkol. 2018 Spring;31(Supplementum1):148-150. Klin Onkol. 2018. PMID: 29808690 Czech.
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L, Sedlarikova L, Kryukov F, Nekvindova J, Radova L, Slaby O, Kuglik P, Almasi M, Penka M, Krejci M, Adam Z, Pour L, Sevcikova S, Hajek R. Besse L, et al. Among authors: slaby o. PLoS One. 2015 Sep 21;10(9):e0137294. doi: 10.1371/journal.pone.0137294. eCollection 2015. PLoS One. 2015. PMID: 26389804 Free PMC article.
[Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
Juráček J, Staník M, Peltanová B, Adamcová S, Doležel J, Fedorko M, Radová L, Slabý O. Juráček J, et al. Among authors: slaby o. Klin Onkol. 2018 Spring;31(Supplementum1):155-157. Klin Onkol. 2018. PMID: 29808692 Czech.
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L, Kryukov F, Slaby O, Dementyeva E, Jarkovsky J, Nekvindova J, Radova L, Greslikova H, Kuglik P, Vetesnikova E, Pour L, Adam Z, Sevcikova S, Hajek R. Kubiczkova L, et al. Among authors: slaby o. Haematologica. 2014 Mar;99(3):511-8. doi: 10.3324/haematol.2013.093500. Epub 2013 Nov 15. Haematologica. 2014. PMID: 24241494 Free PMC article.
Serum miR-29a as a marker of multiple myeloma.
Sevcikova S, Kubiczkova L, Sedlarikova L, Slaby O, Hajek R. Sevcikova S, et al. Among authors: slaby o. Leuk Lymphoma. 2013 Jan;54(1):189-91. doi: 10.3109/10428194.2012.704030. Epub 2012 Aug 14. Leuk Lymphoma. 2013. PMID: 22712836 No abstract available.
[Usage of Cerebrospinal Fluid for microRNA Analysis].
Kopková A, Šána J, Večeřa M, Knoflíčková D, Smrčka M, Slabý O, Fadrus P. Kopková A, et al. Among authors: slaby o. Klin Onkol. 2018 Spring;31(Supplementum1):158-160. Klin Onkol. 2018. PMID: 29808693 Czech.
Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.
Almasi M, Sevcikova S, Slaby O, Kaisarova P, Maisnar V, Penka M, Pika T, Pour L, Radocha J, Scudla V, Svachova H, Hajek R. Almasi M, et al. Among authors: slaby o. Clin Lymphoma Myeloma Leuk. 2011 Oct;11(5):414-20. doi: 10.1016/j.clml.2011.03.024. Epub 2011 May 10. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21859556
362 results